Under this collaboration, Aethlon will analyze brain tissue of professional athletes who suffered from chronic traumatic encephalopathy (CTE) at the time of their death and from individuals without any evidence of brain disease. The research goal is to discover common biomarkers, including dormant viruses that might lead to a diagnostic product able to identify athletes with an increased susceptibility to suffer from CTE.
Deal Type Partnership Sub-Category Research and discovery Deal Status Announced: 2009-11-03
Deal Participants
Partner 1 (Company) Aethlon Medical, Inc. Partner 2 (Company) The Center for the Study of Traumatic Encephalopathy (CSTE)

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index